Holmes Seeks New Trial, Claims Prosecutors Misrepresented Evidence

In a new legal filing, Elizabeth Holmes, the disgraced founder of the defunct blood-testing startup Theranos, is seeking to overturn her conviction, arguing that a key piece of evidence presented by the government was a “false claim.” The motion, filed in federal court, centers on testimony from a former Theranos lab director.

Holmes’s legal team contends that prosecutors inaccurately portrayed statements made by Dr. Adam Rosendorff, who led the company’s lab. They allege the government misled the jury by suggesting Rosendorff believed Theranos was endangering patient health with its flawed Edison devices, when his actual concerns were reportedly about broader laboratory operations.

The filing represents Holmes’s latest attempt to challenge her January 2022 conviction on four counts of defrauding investors. She was sentenced to over 11 years in prison and is currently serving her term at a minimum-security facility in Texas. Her appeal to a higher court is already pending.

This specific motion hinges on the argument that the alleged misrepresentation of Rosendorff’s testimony deprived Holmes of a fair trial. If a judge finds merit in the claim, it could potentially lead to a new trial being ordered, though legal experts consider such an outcome a long shot.

The case, which became a Silicon Valley cautionary tale about the perils of “fake it till you make it” culture, saw Holmes convicted for knowingly misleading investors about Theranos’s technological capabilities. The company, once valued at $9 billion, collapsed after investigations revealed its flagship blood analyzers were unreliable and produced erroneous results.